Hi,
moomoo ID:NaN
Log Out
ENGLISH
  • ENGLISH
  • 中文繁体
  • 中文简体
donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > IMRX Immuneering > Detailed Quotes

IMRX Immuneering

14.130
-0.870-5.80%
Close 10/05 16:00 ET
High
14.799
Open
14.540
Turnover
726.49K
Low
12.900
Pre Close
15.000
Volume
52.46K
Market Cap
372.92M
P/E(TTM)
Loss
52wk High
31.885
Shares
26.39M
P/E(Static)
Loss
52wk Low
3.740
Float Cap
195.36M
Bid/Ask %
95.12%
Historical High
33.990
Shs Float
13.83M
Volume Ratio
0.58
Historical Low
3.740
Dividend TTM
--
Div Yield TTM
--
P/B
2.79
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.38%
Amplitude
12.66%
Avg Price
13.848
Lot Size
1
Float Cap
195.36M
Bid/Ask %
95.12%
Historical High
33.990
Shs Float
13.83M
Volume Ratio
0.58
Historical Low
3.740
Dividend TTM
--
P/B
2.79
Dividend LFY
--
Turnover Ratio
0.38%
Amplitude
12.66%
Avg Price
13.848
Lot Size
1
Price Forecast

No Data

News

Comment

Company Overview More
Immuneering Corp. engages in the development of new medicines which are unlikely to be found by traditional drug discovery methods. Its pipeline of drug candidates focuses on treating aspects of disease that have eluded conventional approaches, including cancer cachexia and metastasis. The company was founded by Robert J. Carpenter and Benjamin J. Zeskind in 2008 and is headquartered in Cambridge, MA.
CEO: Dr. Benjamin J. Zeskind, PhD
Market: NASDAQ
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...